These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 657412)

  • 21. The effects of 2,5-dimethoxy-4-methylamphetamine (DOM) on operant behavior: interactions with other neuroactive agents.
    Commissaris RL; Semeyn DR; Moore KE; Rech RH
    Commun Psychopharmacol; 1980; 4(5):393-404. PubMed ID: 6120791
    [No Abstract]   [Full Text] [Related]  

  • 22. Effect of 2,5-dimethoxy-4-methylamphetamine (DOM, STP) on the uptake and release of 14C-5-hydroxytryptamine by rabbit blood platelets.
    Huang JT; Airaksinen MM; Ho BT
    Eur J Pharmacol; 1974 Feb; 25(2):251-4. PubMed ID: 4435028
    [No Abstract]   [Full Text] [Related]  

  • 23. The effect of mescaline, 3, 4-dimethoxyphenethylamine and 2, 5-dimethoxy-4-methylamphetamine on rat plasma prolactin: evidence for serotonergic mediation.
    Meltzer HY; Fessler RG; Simonovic M; Fang VS
    Life Sci; 1978 Sep; 23(11):1185-92. PubMed ID: 152377
    [No Abstract]   [Full Text] [Related]  

  • 24. QSAR studies on psychotomimetic phenylalkylamines.
    Gupta SP; Handa A; Bindal MC; Singh P
    Arzneimittelforschung; 1983; 33(8):1089-90. PubMed ID: 6685483
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rapid desensitization and down-regulation of 5-HT2 receptors by DOM treatment.
    Leysen JE; Janssen PF; Niemegeers CJ
    Eur J Pharmacol; 1989 Apr; 163(1):145-9. PubMed ID: 2545460
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of 2, 5-dimethoxy-4-methylamphetamine (DOM, STP) on successive sensory discrimination behavior maintained by electrical stimulation of the brain reinforcement in the rat.
    Vincent JH; Lenzer II
    Psychol Rep; 1976 Jun; 38(3 Pt 2):1083-92. PubMed ID: 935303
    [No Abstract]   [Full Text] [Related]  

  • 27. Behavioral effects of 2,5-dimethoxy-4-methylamphetamine (DOM) in rats and mice.
    Yamamoto T; Ueki S
    Eur J Pharmacol; 1975; 32(02):156-62. PubMed ID: 1149803
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Electrochemical study of the hallucinogen (+-)-1-(2,5-dimethoxy-4-nitrophenyl)-2-aminopropane.
    Richter P; Morales A; Gómez-Jeria JS; Morales-Lagos D
    Analyst; 1988 Jun; 113(6):859-63. PubMed ID: 3218759
    [No Abstract]   [Full Text] [Related]  

  • 29. Effects of clozapine and 2,5-dimethoxy-4-methylamphetamine [DOM] on 5-HT2A receptor expression in discrete brain areas.
    Doat-Meyerhoefer MM; Hard R; Winter JC; Rabin RA
    Pharmacol Biochem Behav; 2005 Aug; 81(4):750-7. PubMed ID: 15972234
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Behavioral changes induced by 2,5-dimethoxy 4-methyl-amphetamine (DOM, STP) in primate dyads.
    Tyler CB; Schlemmer RF; Narasimhachari N; Davis JM
    Commun Psychopharmacol; 1978; 2(4):337-42. PubMed ID: 103677
    [No Abstract]   [Full Text] [Related]  

  • 31. Chemical conversion of the psychotomimetic amine 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane to 5-hydroxy-2,6-dimethylindole.
    Zweig JS; Castagnoli N
    J Med Chem; 1974 Jul; 17(7):747-9. PubMed ID: 4836406
    [No Abstract]   [Full Text] [Related]  

  • 32. Distribution profile of 2,5-dimethoxy-4-bromoamphetamine (DOB) in rats after oral and subcutaneous doses.
    Beránková K; Szkutová M; Balíková M
    Forensic Sci Int; 2007 Aug; 170(2-3):94-9. PubMed ID: 17629428
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of d-lysergic acid diethylamide, d-2-bromolysergic acid diethylamide, dl-2,5-dimethoxy-4-methylamphetamine and d-amphetamine on classical conditioning of the rabbit nictitating membrane response.
    Harvey JA; Gormezano I; Cool VA
    J Pharmacol Exp Ther; 1982 May; 221(2):289-94. PubMed ID: 6122729
    [No Abstract]   [Full Text] [Related]  

  • 34. Intraventricular injections of galanin counteract development of head twitches induced by the 5-HT-2 agonist 1-(2,5-dimethoxyphenyl-4-bromo)-2-aminopropane.
    Ogren SO; Fuxe K
    Acta Physiol Scand; 1989 Jun; 136(2):297-8. PubMed ID: 2476910
    [No Abstract]   [Full Text] [Related]  

  • 35. [Transport of 2,5-dimethoxy-4-methylamphetamine by macroheterocycles across erythrocyte membranes].
    Karaseva TL; Iavorskiĭ AS; Pavlovskiĭ VI; Tsapenko ZhN
    Ukr Biokhim Zh (1978); 1993; 65(5):95-8. PubMed ID: 8160305
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stereospecific actions of 2,5-dimethoxy-4-methylamphetamine (DOM) on colonic temperature in the rat at various ambient temperatures.
    Beaton JM; Benington F; Bradley RJ; Kuhlemeier KV; Morin RD
    Br J Pharmacol; 1976 Aug; 57(4):547-50. PubMed ID: 134754
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metabolic pathways of 4-bromo-2,5-dimethoxyphenethylamine (2C-B): analysis of phase I metabolism with hepatocytes of six species including human.
    Carmo H; Hengstler JG; de Boer D; Ringel M; Remião F; Carvalho F; Fernandes E; dos Reys LA; Oesch F; de Lourdes Bastos M
    Toxicology; 2005 Jan; 206(1):75-89. PubMed ID: 15590110
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Profiles of psychedelic drugs: 10. DOB.
    Shulgin A
    J Psychoactive Drugs; 1981; 13(1):99. PubMed ID: 7277091
    [No Abstract]   [Full Text] [Related]  

  • 39. Effects of psychotomimetics on vascular strips: studies of methoxylated amphetamines and optical isomers of 2,5-dimethoxy-4-methylamphetamine and 2,5-dimethoxy-4-bromoamphetamine.
    Cheng HC; Long JP; Nichols DE; Barfknecht CF
    J Pharmacol Exp Ther; 1974 Jan; 188(1):114-23. PubMed ID: 4809263
    [No Abstract]   [Full Text] [Related]  

  • 40. Pathways of metabolism of amphetamine and related compounds.
    Cho AK; Wright J
    Life Sci; 1978 Feb; 22(5):363-72. PubMed ID: 347211
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.